On this page
AP1S2
adaptor related protein complex 1 subunit sigma 2
AP1S2 encodes a subunit of the adaptor protein complex 1 (AP-1), which coordinates the sorting and transport of proteins within cells, particularly in the brain. The AP1S2 gene provides instructions for producing the sigma-2 subunit of the AP-1 adaptor complex, a molecular machine that helps package proteins into transport vesicles.
AP1S2 is located on the short (p) arm of chromosome X, at band Xp22.2. Arm ratio per GRCh38 - banding schematic.
Explore chromosome X in the library →Available at Jeen Health
Clinical tests that include this
Overview
AP1S2 is located on the X chromosome and encodes the sigma-2 subunit of adaptor protein complex 1 (AP-1). This complex plays a central role in intracellular membrane trafficking, ensuring that proteins are correctly sorted and transported between cellular compartments. The gene is predominantly expressed in the nervous system, where precise protein localisation is essential for neuronal function and development.
Pathogenic variants in AP1S2 typically cause X-linked intellectual disability, often accompanied by movement disorders, structural brain abnormalities, and features such as hydrocephalus or intracerebral calcification. Because AP1S2 is inherited in an X-linked pattern, males with a single pathogenic variant are generally more severely affected, whilst females may show variable manifestations depending on patterns of X-chromosome inactivation. The gene appears on multiple NHS clinical panels for neurogenetics conditions, reflecting its importance in diagnosing neurodevelopmental and movement disorders.
What the gene does
The AP1S2 protein functions as the small sigma subunit within the heterotetrameric AP-1 adaptor complex. This complex operates at the trans-Golgi network and endosomal membranes, where it recognises specific sorting signals on cargo proteins and recruits clathrin to form coated vesicles. These vesicles ferry proteins to their correct destinations within the cell, a process critical for maintaining cellular organisation and communication.
AP-1 complexes are particularly important in neurons, where they help traffic synaptic vesicle proteins, neurotransmitter receptors, and other membrane proteins essential for signal transmission. The sigma-2 subunit contributes to cargo recognition by binding to tyrosine-based sorting motifs found in the cytoplasmic tails of transmembrane proteins. Disruption of AP1S2 function impairs the sorting machinery, leading to mislocalisation of proteins and altered neuronal function.
Research suggests that proper AP-1-mediated trafficking is crucial during brain development and for maintaining synaptic plasticity. When AP1S2 is non-functional, the resulting defects in vesicle formation and protein sorting appear to particularly affect regions involved in motor control and cognition, explaining the neurological phenotype observed in affected individuals.
Video: Genetics 101
Chromosome location
AP1S2 is located on the short arm of the X chromosome at position Xp22.2. This region is part of the terminal segment of the X chromosome's short arm, a genomically active area containing numerous genes involved in neurological function and development. The X-linked location of AP1S2 accounts for the inheritance pattern seen in affected families, where males are typically more severely affected and females may be carriers with variable clinical features.
Protein structure
While detailed domain boundaries have not been formally annotated, structural studies of related adaptor complexes indicate that AP1S2 (157 amino acids) likely adopts a compact fold facilitating interaction with cargo signals and larger AP-1 subunits.
Key variants
Pathogenic variants in AP1S2 are predominantly loss-of-function changes, including nonsense variants, frameshift deletions or insertions, and splice-site alterations that disrupt normal protein production. Missense variants affecting critical residues involved in cargo recognition or subunit assembly have also been reported. The majority of documented pathogenic variants lead to absent or severely reduced AP1S2 function, consistent with loss-of-function being sufficient to cause disease in males (who have only one X chromosome).
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.-1+1G>A | - | Pathogenic/Likely pathogenic | ★★☆☆ | Pettigrew syndrome |
c.154C>T | p.Arg52Ter | Pathogenic | ★★☆☆ | AP1S2-related disorder |
c.367C>T | p.Gln123Ter | Pathogenic | ★★☆☆ | Pettigrew syndrome |
c.1-3C>A | - | Pathogenic | ★☆☆☆ | Pettigrew syndrome |
c.178dup | p.Arg60fs | Pathogenic | ★☆☆☆ | not provided |
c.281del | p.Phe94fs | Pathogenic | ★☆☆☆ | Pettigrew syndrome |
c.288+1G>A | - | Pathogenic | ★☆☆☆ | Pettigrew syndrome |
c.289-2A>G | - | Pathogenic | ★☆☆☆ | not provided |
c.319del | p.Glu107fs | Pathogenic | ★☆☆☆ | Pettigrew syndrome |
c.40C>T | p.Arg14Ter | Pathogenic | ★☆☆☆ | not provided |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Pathogenic variants in AP1S2 cause X-linked intellectual disability, often accompanied by a spectrum of neurological features. Affected males typically present with moderate to severe developmental delay, speech impairment, and cognitive deficits. Many individuals also exhibit movement disorders such as dystonia, chorea, or ataxia, reflecting dysfunction in the basal ganglia and cerebellum.
Structural brain abnormalities are common and may include hydrocephalus, white matter changes, or intracerebral calcification, particularly affecting the basal ganglia. Some affected individuals also show cerebellar structural changes such as cerebellar hypoplasia. Female carriers may remain asymptomatic or exhibit milder features, though skewed X-inactivation can occasionally result in a clinical presentation similar to affected males. The range of associated features reflects the broad importance of AP-1-mediated trafficking in neuronal development and maintenance.
No disease links recorded for this gene in our reference set.
Inheritance pattern
Conditions caused by pathogenic AP1S2 variants typically follow x-linked inheritance.
X-linked recessive: sons of a carrier mother have a 50% chance of being affected. Daughters have a 50% chance of being carriers.
UK clinical status
AP1S2 appears on multiple NHS Genomic Medicine Service panels with green classification, indicating strong evidence for its involvement in neurogenetic conditions. These include the Intellectual Disability panel (R29), Childhood Onset Dystonia, Chorea or Related Movement Disorder panel (R57), and Hereditary Ataxia panel (R51). The gene is also listed on panels for Ataxia and Cerebellar Anomalies, Structural Basal Ganglia Disorders, White Matter Disorders and Cerebral Calcification, Hydrocephalus (R86), Fetal Anomalies (R21), and Intracerebral Calcification Disorders. This broad representation across NHS panels reflects the diverse neurological manifestations associated with AP1S2 variants and supports its use in diagnostic genomic testing for individuals presenting with intellectual disability, movement disorders, or structural brain abnormalities.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Diet & lifestyle considerations
No specific lifestyle modifications have been shown to modify the neurological features associated with AP1S2-related conditions.
Supplement considerations
No dietary supplements or micronutrient therapies have been established to modify AP1S2-related conditions.
Frequently asked questions
How is AP1S2-related intellectual disability inherited?
AP1S2-related conditions follow an X-linked inheritance pattern. Males who inherit a pathogenic variant are typically affected, whilst females are usually carriers with variable clinical features depending on X-inactivation patterns. Affected males cannot pass the condition to their sons but will pass the variant to all daughters, who become carriers.
Why do AP1S2 variants cause neurological symptoms?
AP1S2 encodes a component of the protein-sorting machinery that is particularly important in neurons. Pathogenic variants disrupt the trafficking of synaptic proteins and neurotransmitter receptors, impairing neuronal communication and development. This leads to intellectual disability, movement disorders, and structural brain abnormalities.
Can females with an AP1S2 variant be affected?
Yes, although females typically have a second, normal copy of the gene on their other X chromosome, some female carriers exhibit clinical features ranging from mild learning difficulties to more pronounced neurological symptoms. The severity in females depends on the pattern of X-chromosome inactivation in their cells.